Articles written by: Raymond Wells

Eiger BioPharmaceuticals Inc. (EIGR) and Aimmune Therapeutics Inc. (NASDAQ:AIMT) Contrasting side by side

As Biotechnology companies, Eiger BioPharmaceuticals Inc. (NASDAQ:EIGR) and Aimmune Therapeutics Inc. (NASDAQ:AIMT) are our subject to compare. And more specifically their analyst recommendations, profitability, risk, dividends, institutional ownership, earnings and valuation. Valuation and Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Eiger BioPharmaceuticals Inc. 14 0.00 […]

Reviewing Neuberger Berman High Yield Strategies Fund Inc. (NHS)’s and THL Credit Inc. (NASDAQ:TCRD)’s results

We will be comparing the differences between Neuberger Berman High Yield Strategies Fund Inc. (NYSE:NHS) and THL Credit Inc. (NASDAQ:TCRD) as far as risk, institutional ownership, analyst recommendations, profitability, dividends, earnings and valuation are concerned. The two businesses are rivals in the Asset Management industry. Earnings & Valuation Gross Revenue […]

Reviewing Iovance Biotherapeutics Inc. (IOVA)’s and Immutep Limited (NASDAQ:IMMP)’s results

As Biotechnology businesses, Iovance Biotherapeutics Inc. (NASDAQ:IOVA) and Immutep Limited (NASDAQ:IMMP), are affected by contrast. This especially applies to their analyst recommendations, profitability, risk, institutional ownership, dividends, earnings and valuation. Valuation & Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Iovance Biotherapeutics Inc. 26 0.83 103.67M […]

Pulse Biosciences Inc. (PLSE)’s Financial Results Comparing With Sientra Inc. (NASDAQ:SIEN)

As Medical Instruments & Supplies companies, Pulse Biosciences Inc. (NASDAQ:PLSE) and Sientra Inc. (NASDAQ:SIEN) are our subject to compare. And more specifically their institutional ownership, profitability, risk, analyst recommendations, dividends, earnings and valuation. Valuation and Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Pulse Biosciences Inc. […]

Reviewing Gossamer Bio Inc. (GOSS)’s and Krystal Biotech Inc. (NASDAQ:KRYS)’s results

Gossamer Bio Inc. (NASDAQ:GOSS) and Krystal Biotech Inc. (NASDAQ:KRYS) compete with each other in the Biotechnology sector. We will analyze and contrast their dividends, analyst recommendations, institutional ownership, profitability, risk, earnings and valuation. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Gossamer Bio Inc. […]

Rafael Holdings Inc. (RFL)’s Financial Results Comparing With Loxo Oncology Inc. (:)

Rafael Holdings Inc. (NYSE:RFL) and Loxo Oncology Inc. (:) compete with each other in the Biotechnology sector. We will analyze and compare their analyst recommendations, profitability, risk, dividends, institutional ownership, earnings and valuation. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Rafael Holdings Inc. […]

Contrasting of Cameco Corporation (CCJ) and Compass Minerals International Inc. (NYSE:CMP)

Both Cameco Corporation (NYSE:CCJ) and Compass Minerals International Inc. (NYSE:CMP) are each other’s competitor in the Industrial Metals & Minerals industry. Thus the compare of their institutional ownership, profitability, analyst recommendations, risk, dividends, earnings and valuation. Valuation and Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio […]

Reviewing Aeglea BioTherapeutics Inc. (AGLE)’s and Altimmune Inc. (NASDAQ:ALT)’s results

This is a contrast between Aeglea BioTherapeutics Inc. (NASDAQ:AGLE) and Altimmune Inc. (NASDAQ:ALT) based on their dividends, analyst recommendations, profitability, risk, institutional ownership, earnings and valuation. The two companies are Biotechnology and they also compete with each other. Valuation & Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share […]